This company provides a platform for conducting clinical trials remotely, collecting real-world data through wearable sensors and machine learning. Their system enables pharmaceutical companies to gather comprehensive patient data, including motion, speech, and physiological information, within the patient's home, reducing costs and improving data quality.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional clinical trials often struggle with recruiting and retaining participants, acquiring objective and sensitive data, and capturing real-world context, leading to delays and increased costs in pharmaceutical R&D. Current methods often lack the ability to detect meaningful changes in a patient's function in their daily life.
Solution
WKD.SMRT offers a user-friendly, in-home IoT+AI platform designed to deliver superior, real-world data for clinical trials, particularly for neurodegenerative diseases. The platform combines multiple IoT sensor nodes for kinematic motion capture, a tablet for patient interaction, and a hub for edge computing and connectivity to WKD.SMRT’s cloud. This end-to-end solution provides secure APIs for data-as-a-service, enabling more sensitive and complete data collection in a patient's natural environment. By measuring smaller effect sizes with greater specificity and selectivity across representative populations, WKD.SMRT aims to de-risk and accelerate clinical trials.
Target Audience
The primary target audience includes pharmaceutical companies and clinical research organizations focused on neurodegenerative and other diseases involving motor dysfunction or changes in activity, seeking to improve the efficiency and data quality of their clinical trials.
Features
- Ambient kinematic motion capture using 3D sensor nodes
- Tablet interface for patient interaction and data input
- Hub device for biomarker extraction, local data processing, and secure connectivity (WiFi and 5G)
- Cloud-based data storage and analytics with secure APIs for data access
- Support for third-party wearables and sensors to enhance data collection
- AI-powered data processing for Activities of Daily Living (ADL) and Quality of Life (QoL) assessments
- End-to-end solution designed for ease of use by both patients and pharmaceutical companies